SHE Level 5
SCQF Credit Points 20.00
ECTS Credit Points 10.00
Module Code MMB524505
Module Leader Laura Sweeney
School School of Health and Life Sciences
Subject Vision Sciences
  • C (May start)-A (September start)
  • S-C (May start)-A (September start)
  • A (September start)
  • B (January start)-C (May start)
  • C (May start)

Pre-Requisite Knowledge

MMB524504 - Ocular Therapeutics

Summary of Content

The module is designed to advance the understanding of the pharmacology of ocular therapeutic drugs and their application in the management of anterior eye disease and Glaucoma. It introduces students to a critical assessment of available optometric and medical strategies of ocular disease within an informed and flexible approach taking patients special needs, beliefs and preferences into consideration. The module further introduces the concepts of evidence-based practice within the framework of clinical governance.


Theoretical and practical aspects of investigations into Glaucoma, including IOP, ONH, VF, pachymetry, OCT & Gonioscopy Diagnosis of Glaucoma Management of Glaucoma - IOP and Glaucoma medication Pharmacology of ocular antimicrobial agents Anti-inflammatory therapy of ocular disease Signs, symptoms, differential diagnosis and management of Episcleritis, Sceritis and Uveitis Signs, symptoms, differential diagnosis and management of infectious Keratitis Monitoring compliance and response to treatment Knowledge of natural progress of conditions being treated Clinical Management guidelines and referral guidelines Sources of drug information Clinical Governance in relation to prescribing Evidence based practice Reflective practice Pain management Laboratory investigations relevant to ocular disease

Learning Outcomes

Following successful completion of this module, the students should be able to:-1. Demonstrate an understanding of the principal signs and symptoms likely to be associated with various types of Glaucoma and to conduct appropriate ophthalmic investigations2. Recognise the presence of Glaucoma-related eye disease, make a differential diagnosis and make decisions on the appropriate management strategies, including non-pharmacological & pharmacological treatment, shared management and referral.3. Demonstrate an ability to develop and document a management plan for various anterior ocular diseases and Glaucoma independently or, where appropriate, within the context of a prescribing partnership4. Demonstrate an ability to critically evaluate sources of information, advice and decision support in prescribing practice, taking into account current evidence based practice5. Demonstrates an understanding of clinical governance6. Demonstrate an understanding of relevant management guidelines and appropriate referral procedures. 7. Demonstrate an understanding of the main concepts relevant to communication and interaction with other health care professionals pertinent to the management of abnormal ocular conditions and eye diseases

Teaching / Learning Strategy

This module will comprise of a two day session of lectures and practicals. The remainder of the module will employ a distance learning format with directed learning. Students will be provided with a series of articles and online resources. Continuous formative assessments will be used on all reading material to facilitate learning and consolidate successful acquisition of learning outcomes. Additional learning modalities may include recorded lectures, webinars and interactive on-line discussion forums -28

Indicative Reading

Required reading: Module articles College of Optometrist Clinical Management Guidelines Supplementary reading: References in Module Articles European Glaucoma Society Guidelines Alastair Denniston, Oxford Handbook of Ophthalmology, 3rd Edition, 2014, OUP Oxford Timothy L Jackson, Moorfield's Manual of Ophthalmology, 2nd Edition, 2014, JP Medical Ltd Brad Bowling, Kanski's Clinical Ophthalmology: A Systematic Approach, 8th Edition, 2015, Butterworth-Heinemann, London Doughty MJ. Drugs, medications and the Eye (current edition), Smawcastellane Information Services, Scotland. Hopkins & Pearson, Ophthalmic drugs: Diagnostic and therapeutic uses, 2007, Butterworth and Heinemann Duncan Richards, Oxford Handbook of Practical Drug Therapy, 2nd Edition, 2011, OUP Oxford Thirmurthy Velpandian, Pharmacology of Ocular Therapeutics, 2016, Adis UK Monthly Index of Medical Specialities (MIMS), (current edition) British National Formulary (BNF), (current edition) Royal College of Ophthalmologists Clinical Guidelines Scottish Intercollegiate Network (SIGN) guidelines relevant to ocular conditions National Institute for Health and Care Excellence (NICE) clinical guidelines relevant to ocular conditionsa

Transferrable Skills

Ability to communicate with patients and other health care providers Ability to conduct a structured examination Ability to formulate and test clinical hypotheses Ability to interpret clinical data to aid decision making Ability to develop a management plan within the context of evidence based practice Ability to critically evaluate clinical evidence Ability to reflect on all aspects of patient-practitioner interaction

Module Structure

Activity Total Hours
n/a 10.00
Independent Learning (FDL) 164.00
Practicals (FDL) 6.00
Assessment (FDL) 20.00

Assessment Methods

Component Duration Weighting Threshold Description
Exam 01 2.00 75.00 45% Unseen written exam paper
Course Work 01 n/a 25.00 45% Case studies